Apocynum Venetum (Luo Bu Ma)
Also called luo bu ma, luobuma, Venetron, Apocynum venetum leaf extract, AVLE, dogbane leaf.
Best grade D across 2 graded outcomes Botanical Last checked
The short answer
From 5 sourcesApocynum venetum (luo bu ma) leaf is a traditional Chinese tea herb. In a small supplier-run study, 50 mg of extract before bed for one week added 7.6% non-REM sleep versus placebo, mostly light sleep. A larger open 2023 trial saw sleep improve on the extract, but placebo improved too. The plant contains cymarin, a cardiac glycoside.
Every graded outcome on this page
2 rows · line = participantsKey facts
- Sleep
- 50 mg of leaf extract 30 minutes before bed for 1 week increased non-REM sleep time by 7.6% vs placebo on home EEG, but the added sleep was mostly light non-REM sleep and deep-sleep (delta) power did not change1
- Study size
- 16 adults with poor sleep were split into 4 matched groups of 4, not randomized; 15 contributed data, with 8 assessments on the extract alone1
- Larger 2023 trial
- In an open crossover trial (106 workers with poor sleep analysed), sleep-questionnaire scores improved during a week of 50 mg/day extract, but they also improved during the placebo week, and the extract was not tested directly against placebo5
- Industry ties
- The authors worked for Pharma Foods International and Tokiwa Phytochemical, the companies supplying the GABA and the Venetron extract1
- Active compounds
- The extract was standardized to at least 4% hyperoside and isoquercitrin, two quercetin glycosides1
- Adulteration
- A related species, Apocynum pictum, is often sold in its place, which may affect safety and effect2
- Cardiac glycoside
- The plant contains cymarin, a cardiac glycoside; in one lab analysis the leaf held far less than the stems, and the Venetron extract the least4
What it is
Apocynum venetum, or luo bu ma, is a Chinese herb whose leaves are brewed as tea and sold as a standardized extract (Venetron) for sleep.
How it works
ProposedThe leaves are rich in flavonoids, mainly hyperoside and isoquercitrin. The sleep study's authors suggest these quercetin glycosides may act on the brain, and reviews describe anxiolytic, antidepressant-like and blood-pressure-lowering effects, mostly from animal studies. None of this is established in people. The plant also contains cymarin, a cardiac glycoside, and extracts had a weak heart-stimulating effect on isolated guinea-pig heart tissue.1234
Forms, side by side
2 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Apocynum Venetum (Luo Bu Ma) forms compared
2 forms| 2 forms | Standardized leaf extract (Venetron) | Luobuma leaf tea |
|---|---|---|
| Absorption in people | Not measured in humans.1 | No human data in our sources.2 |
| GI tolerance | No worsening on sleep questionnaires; adverse events were not reported in detail.1 | No controlled human safety data in our sources.23 |
| Studied for | Sleep | Traditional use only |
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
2 graded outcomes, largest study first2 graded outcomes: 1 improved, 1 mixed. The largest, a 2023 crossover trial of 106 people on Self-rated sleep problems (OSA sleep questionnaire), found mixed results.
1Self-rated sleep problems (OSA sleep questionnaire)
Mixed · Grade D · Crossover RCT, 106 people, 2023
Healthy, non-depressed full-time workers with poor sleep (PSQI above 5), Japan; 160 enrolled, 106 analysed
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Self-rated sleep problems (OSA sleep questionnaire) | Mixed | 106 | Grade D · Crossover RCT, 2023 | Healthy, non-depressed full-time workers with poor sleep (PSQI above 5), Japan; 160 enrolled, 106 analysed |
| Non-REM sleep time and self-rated sleep quality | Improved | 15 | Grade D · Open-label trial, 2015 | Adults with poor sleep (PSQI 6 or higher), mean age about 37 (Japan) |
Every graded row
2 rowsDGrade DSelf-rated sleep problems (OSA sleep questionnaire)SleepBetter than baseline; placebo also improvedCrossover RCT
n 106 · 2023
Mixed Sleep-questionnaire scores improved from baseline during the extract week, but they also improved during the placebo and mindfulness weeks. Each period was compared with baseline only; the extract was not tested directly against placebo.
- Design
- Crossover RCT, n = 106, 2023
- Population
- Healthy, non-depressed full-time workers with poor sleep (PSQI above 5), Japan; 160 enrolled, 106 analysed
- Form
- Apocynum venetum leaf extract (AVLE); L-theanine, GABA, L-serine, placebo and mindfulness periods also tested
- Dose
- 50 mg/day
- Duration
- 7 days per period, washouts of at least 7 days
- Source
- Reference 5 · PubMed 37242260 (opens PubMed)
DGrade DNon-REM sleep time and self-rated sleep qualitySleep+7.6% non-REM sleep timeOpen-label trial
n 15 · 2015
Improved Non-REM sleep time rose 7.6% vs placebo (p < 0.01) on single-channel home EEG, but most of the added non-REM sleep was light sleep and delta-wave power, a marker of deep sleep, did not differ from placebo. The PSQI improvement with the extract was only a non-significant trend (p = 0.10).
- Design
- Open-label trial, n = 15, 2015
- Population
- Adults with poor sleep (PSQI 6 or higher), mean age about 37 (Japan)
- Form
- Apocynum venetum leaf extract (Venetron, ≥4% hyperoside and isoquercitrin) vs dextrin placebo; GABA and combination arms also tested
- Dose
- 50 mg 30 minutes before bed
- Duration
- 1 week per period, 1-week washout
- Source
- Reference 1 · PubMed 26052150 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
No head-to-head win over placebo yet
The 2015 study compared the extract with placebo in only 8 assessments over one week, and the larger 2023 trial compared each week only with baseline, during which placebo also improved sleep. Both were run by company researchers: the extract's suppliers in 2015 and food maker Ezaki Glico in 2023.15
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
What Apocynum Venetum meets
2 cited rows 1 tested togetherMedicines 2
Supplements and foods 1
- Reference summary
- Tested together in a graded trial
Choose a medicine or supplement above to read its cited rows here.
Also cited: 1 tested together
Blood-pressure medicines and diuretics
ReviewReference summary
Blood-pressure medicines and diuretics, for example ACE inhibitors, beta-blockers, calcium-channel blockers, water pills: Reviews describe blood-pressure-lowering effects in animal studies, so taking it with these medicines could lower blood pressure further. Not studied in people.
Digoxin and other heart-glycoside medicines
ReviewReference summary
Digoxin and other heart-glycoside medicines, for example Digoxin (Lanoxin): Apocynum venetum contains cymarin, a cardiac glycoside from the same drug class as digoxin, and its extracts stimulated isolated heart tissue in a lab study. Effects could add up; no human interaction studies exist.
Source 4, J Nat Med (2009); Source 3, J Ethnopharmacol (2012)
GABAGABA page
Tested together
Non-REM sleep time and self-rated sleep quality. Graded on the Apocynum Venetum page; tested together is not a claim that they work better together.
Interactions
2 agents| Agent | What the source says | Evidence |
|---|---|---|
| Medicines2 | ||
| Digoxin and other heart-glycoside medicinese.g. Digoxin (Lanoxin) | Apocynum venetum contains cymarin, a cardiac glycoside from the same drug class as digoxin, and its extracts stimulated isolated heart tissue in a lab study. Effects could add up; no human interaction studies exist.43 | Review |
| Blood-pressure medicines and diureticse.g. ACE inhibitors, beta-blockers, calcium-channel blockers, water pills | Reviews describe blood-pressure-lowering effects in animal studies, so taking it with these medicines could lower blood pressure further. Not studied in people.32 | Review |
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Apocynum Venetum and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Apocynum Venetum.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
5 groups- People on blood-pressure or heart medicines
- The plant contains cymarin, a cardiac glycoside, and reviews describe blood-pressure-lowering and cardiotonic effects in animal studies. No human interaction studies exist, so effects alongside digoxin, blood-pressure medicines or diuretics are unknown.423
- People with low blood pressure
- Animal studies describe blood-pressure-lowering effects, so people with low blood pressure, or who feel faint on standing, may be more affected. This has not been studied in people.32
- Pregnancy and breastfeeding
- No study included pregnant or breastfeeding women, and LactMed (the NIH breastfeeding database) has no entry for this herb, so there are no safety data for them. The plant contains cymarin, a cardiac glycoside.154
- Long-term use
- Controlled human data that we could check cover 1-week periods (16 adults in 2015, 106 workers in 2023). A 2012 review reports no severe side effects in animal studies and clinical trials, including 50 mg a day for over three years, but those long-term data were not available to verify. LiverTox has no entry for the herb.153
- Product identity
- Apocynum pictum is often substituted for Apocynum venetum, so what is in a product may differ from what was studied.2
How to read the label
What to check on the Supplement Facts panel.
How to read the label
2 checksFrequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
6 answersDoes Apocynum venetum help sleep?
Does luo bu ma lower blood pressure?
Is Apocynum venetum safe?
Is luobuma tea the same as the Venetron extract?
What is luo bu ma?
What is Venetron?
A branded Apocynum venetum leaf extract from Tokiwa Phytochemical, standardized to hyperoside and isoquercitrin; it is the extract used in the sleep study.1
Sources
5 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
5 sources- 1The Improvement of Sleep by Oral Intake of GABA and Apocynum venetum Leaf Extract.Open-label trial J Nutr Sci Vitaminol (Tokyo), 2015 · PMID 26052150
- 2Apocynum venetum, a medicinal, economical and ecological plant: a review update.Review PeerJ, 2023 · PMID 36908824
- 3Botany, traditional uses, phytochemistry and pharmacology of Apocynum venetum L. (Luobuma): A review.Review J Ethnopharmacol, 2012 · PMID 22421379
- 4Cardiotonic effect of Apocynum venetum L. extracts on isolated guinea pig atrium.Animal study J Nat Med, 2009 · PMID 19002560
- 5Analysis of the Effects of Known Sleep-Support Supplements in Relation to Life Habits, Sleep Conditions, and Sleep Problems.Crossover RCT Nutrients, 2023 · PMID 37242260
What changed
Every dated change to this page: what changed, who made it and why.
Change log
3 entries| Date | Change | Who and why |
|---|---|---|
| summary, key facts, evidence, studied doses, who should avoid, FAQ, questions, related | Re-searched PubMed for human Apocynum venetum studies: added the 2023 open randomized crossover trial (PMID 37242260; 106 workers analysed, 50 mg/day for 7-day periods; period length, placebo arm and analysed number read in PMC10220724). It compared each period with baseline only and placebo also improved, so it is graded D with a mixed result. Rewrote the summary and insight to match. No LactMed or LiverTox entry exists for the herb (checked), so the pregnancy and long-term notes say so; no NCCIH or MedlinePlus page either, so interactions are unchanged (cymarin/digoxin and blood-pressure rows stand). Added FAQ on tea versus extract and on blood pressure, questions this page answers, and the sleep goal-hub link. | Writer: Kymata Health EditorialTrigger: A–Z audit against docs/supplements/AUDIT-STANDARD.md |
| all | Initial editorial evidence review (first draft). Every PMID checked against NCBI E-utilities esummary (titles and years taken from the record, none retracted) and the abstract read for each cited row. Studied doses are reported as research doses, not dosing advice. | Writer: Kymata Health EditorialTrigger: new page |
| evidence, key facts, interactions, who should avoid | Review fixes: 2015 sleep study relabelled open-label (16 people in 4 matched groups, not randomized; n = 15 after one illness dropout), result narrowed to light non-REM sleep with no delta-power change and a non-significant PSQI trend; 'Funding' renamed 'Industry ties'; cymarin (Irie 2009, PMID 19002560) added with digoxin and blood-pressure/diuretic interactions and a low-blood-pressure caution. Checked against the full text of PMID 26052150 and the abstract of PMID 19002560. | Writer: Kymata Health EditorialTrigger: adversarial review |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.